Lung Cancer Europe shared a post on LinkedIn:
“New Lancet review highlights the surge in cancer vaccine research. 200+ trials now running globally. Lung cancer is part of this emerging field – but still under-represented compared to melanoma, breast and others.
We need stronger inclusion:
more global lung cancer vaccine trials
wider access across European countries
diverse patient populations included
Every cancer. Every patient.”
Title: Cancer vaccines and the future of immunotherapy
Authors: Orrin Pail, Matthew J Lin, Theodora Anagnostou, Brian D Brown, Joshua D Brody
Read the Full Article.
